ALDH1A2 and amyotrophic lateral sclerosis: This study uses the Tg(SOD1*G93A)1Gur/J transgenic mouse model to understand the pathogenesis of ALS and explores the regulatory mechanisms of APG on ALDH1A2, thus laying the foundation for potential clinical applications of APG for ALS patients.